PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Stock Pump Blog, page-2

  1. 288 Posts.
    lightbulb Created with Sketch. 79
    HAHAHAHAHAAH. Carton of tins in?

    I doubt any scientist of this calibre would put their professional integrity on the line for anything except a molecule like this, that is solving a problem like grades 2/3/4 OA. Paul regularly states our data is reviewed by key opinion leaders, we have consultants and it’s not hard to find out who these individuals are. Mozz has got off his own backside and travelled to OARSI, and with his very own set of eyeballs, seen these people in person. Detailed retail analysis
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.